BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bray MA, Sartain SE, Gollamudi J, Rumbaut RE. Microvascular thrombosis: experimental and clinical implications. Transl Res 2020;225:105-30. [PMID: 32454092 DOI: 10.1016/j.trsl.2020.05.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Alavi P, Rathod AM, Jahroudi N. Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor. J Clin Med 2021;10:4190. [PMID: 34575297 DOI: 10.3390/jcm10184190] [Reference Citation Analysis]
2 Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas) 2021;57:833. [PMID: 34441038 DOI: 10.3390/medicina57080833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
4 Mukherjee AK, Chattopadhyay DJ. Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19. Phytother Res 2022. [PMID: 35147268 DOI: 10.1002/ptr.7408] [Reference Citation Analysis]
5 Kanoore Edul VS, Caminos Eguillor JF, Ferrara G, Estenssoro E, Siles DSP, Cesio CE, Dubin A. Microcirculation alterations in severe COVID-19 pneumonia. J Crit Care 2021;61:73-5. [PMID: 33096349 DOI: 10.1016/j.jcrc.2020.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Filgueira TO, Castoldi A, Santos LER, de Amorim GJ, de Sousa Fernandes MS, Anastácio WLDN, Campos EZ, Santos TM, Souto FO. The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences. Front Immunol 2021;12:587146. [PMID: 33613573 DOI: 10.3389/fimmu.2021.587146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
7 Ramos SG, Rattis BADC, Ottaviani G, Celes MRN, Dias EP. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients. Am J Pathol 2021;191:1154-64. [PMID: 33964216 DOI: 10.1016/j.ajpath.2021.04.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gillespie AH, Doctor A. Red Blood Cell Contribution to Hemostasis. Front Pediatr 2021;9:629824. [PMID: 33869111 DOI: 10.3389/fped.2021.629824] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Vilela TS, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematol Transfus Cell Ther 2021;43:87-100. [PMID: 33289008 DOI: 10.1016/j.htct.2020.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
11 Gonzalez-Gonzalez FJ, Ziccardi MR, McCauley MD. Virchow's Triad and the Role of Thrombosis in COVID-Related Stroke. Front Physiol 2021;12:769254. [PMID: 34858214 DOI: 10.3389/fphys.2021.769254] [Reference Citation Analysis]
12 Courson JA, Hanlon SD, Bray MA, Lam FW, Burns AR, Rumbaut RE. Serial block-face scanning electron microscopy: A provocative technique to define 3-dimensional ultrastructure of microvascular thrombosis. Thromb Res 2020;196:519-22. [PMID: 33099176 DOI: 10.1016/j.thromres.2020.10.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Alencar VNS, Nascimento MCD, Ferreira JVDS, Batista JMDS, Cunha MNCD, Nascimento JMD, Sobral RVDS, Couto MTTD, Nascimento TP, Costa RMPB, Porto ALF, Leite ACL. Purification and characterization of fibrinolytic protease from Streptomyces parvulus by polyethylene glycol-phosphate aqueous two-phase system. An Acad Bras Cienc 2021;93:e20210335. [PMID: 34909841 DOI: 10.1590/0001-3765202120210335] [Reference Citation Analysis]
14 Bull BS, Hay KL. A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia. Immun Inflamm Dis 2021. [PMID: 34231951 DOI: 10.1002/iid3.482] [Reference Citation Analysis]
15 Henry BM, Cheruiyot I, Benoit JL, Lippi G, Prohászka Z, Favaloro EJ, Benoit SW. Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study. Semin Thromb Hemost 2021;47:451-5. [PMID: 33482678 DOI: 10.1055/s-0040-1722308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Keramidas G, Gourgoulianis KI, Kotsiou OS. Venous Thromboembolic Disease in Chronic Inflammatory Lung Diseases: Knowns and Unknowns. J Clin Med 2021;10:2061. [PMID: 34064992 DOI: 10.3390/jcm10102061] [Reference Citation Analysis]
17 Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, Pandit A, Ray BK, Benito-León J. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021;15:1039-45. [PMID: 34015627 DOI: 10.1016/j.dsx.2021.04.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Cañas CA, Cañas F, Bautista-Vargas M, Bonilla-Abadía F. Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It. Clin Appl Thromb Hemost 2021;27:10760296211003983. [PMID: 33784877 DOI: 10.1177/10760296211003983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Bull BS, Hay KL, Herrmann PC. Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy? JCM 2022;11:2084. [DOI: 10.3390/jcm11082084] [Reference Citation Analysis]
20 Gandhi AA, Estes SK, Rysenga CE, Knight JS. Understanding the Pathophysiology of Thrombotic APS through Animal Models. Int J Mol Sci 2021;22:2588. [PMID: 33806694 DOI: 10.3390/ijms22052588] [Reference Citation Analysis]
21 Elkind MSV, Harrington RA, Lloyd-Jones DM. COVID-19 at 1 Year: American Heart Association Presidents Reflect on the Pandemic. Circulation 2021;143:e746-8. [PMID: 33646828 DOI: 10.1161/CIRCULATIONAHA.120.053439] [Reference Citation Analysis]
22 Nasif WA, El-moursy Ali AS, Hasan Mukhtar M, Alhuzali AMH, Yahya Alnashri YA, Ahmed Gadah ZI, Edrees EAA, Albarakati HAM, Muhji Aloufi HS, Hassen K. Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review. Anemia 2022;2022:1-9. [DOI: 10.1155/2022/9104209] [Reference Citation Analysis]
23 Wang C, Yu C, Novakovic VA, Xie R, Shi J. Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury. Front Cell Dev Biol 2022;9:784505. [DOI: 10.3389/fcell.2021.784505] [Reference Citation Analysis]
24 Zhang Y, Ramasundara SZ, Preketes-Tardiani RE, Cheng V, Lu H, Ju LA. Emerging Microfluidic Approaches for Platelet Mechanobiology and Interplay With Circulatory Systems. Front Cardiovasc Med 2021;8:766513. [PMID: 34901226 DOI: 10.3389/fcvm.2021.766513] [Reference Citation Analysis]
25 Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Reference Citation Analysis]